elafibranor
Showing 1 - 8 of 8
Primary Biliary Cholangitis (PBC) Trial (Elafibranor, Matched 80 mg )
Not yet recruiting
- Primary Biliary Cholangitis (PBC)
- Elafibranor
- Matched 80 mg placebo
- (no location specified)
Aug 29, 2023
Healthy Volunteers Trial (Elafibranor)
Not yet recruiting
- Healthy Volunteers
- Elafibranor
- (no location specified)
Sep 14, 2022
Healthy Participants Trial in Rennes (elafibranor)
Completed
- Healthy Participants
- elafibranor
-
Rennes, FranceBIOTRIAL
Jan 26, 2023
Drug-drug Interaction Trial in Gières (elafibranor, CHRONO-INDOCID)
Completed
- Drug-drug Interaction
- elafibranor
- CHRONO-INDOCID
-
Gières, FranceEurofins Optimed Clinical Pharmacology Unit
Aug 12, 2020
Geriatrics, Healthy Trial in Rennes (elafibranor)
Completed
- Geriatrics
- Healthy
- elafibranor
-
Rennes, FranceBIOTRIAL
Aug 12, 2020
Renal Impairment, Renal Insufficiency, Kidney Diseases Trial in Gières, Bucharest (Elafibranor)
Completed
- Renal Impairment
- +3 more
- Elafibranor
-
Gières, France
- +1 more
Aug 12, 2020
Nonalcoholic Steatohepatitis (NASH) With Fibrosis Trial in Worldwide (Elafibranor, Placebo)
Terminated
- Nonalcoholic Steatohepatitis (NASH) With Fibrosis
- Elafibranor
- Placebo
-
Birmingham, Alabama
- +325 more
Feb 25, 2022
Hepatic Impairment, Liver Disease, Pharmacokinetics Trial in Miami (Elafibranor)
Completed
- Hepatic Impairment
- +2 more
- Elafibranor
-
Miami, Florida
- +1 more
Aug 21, 2019